Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Gelaspan 4% infusion 500ml Ecobags
0902022I0BFAAAA
|
Gelaspan | Gelatin | Nutrition and Blood | 3 |
|
Gelaspan 4% infusion 1litre Ecobags
0902022I0BFABAC
|
Gelaspan | Gelatin | Nutrition and Blood | No data available |
|
Gelatin 4% infusion 1litre bags
0902022I0AAACAC
|
Gelatin | Gelatin | Nutrition and Blood | No data available |
|
Gelatin 4% infusion 500ml bags
0902022I0AAAAAA
|
Gelatin | Gelatin | Nutrition and Blood | No data available |
|
Gelofusine 4% infusion 1litre Ecobags
0902022I0BBACAC
|
Gelofusine | Gelatin | Nutrition and Blood | No data available |
|
Gelofusine 4% infusion 500ml Ecobags
0902022I0BBABAA
|
Gelofusine | Gelatin | Nutrition and Blood | No data available |
|
Haemaccel 17.5g/500ml solution for injection bottles
0902022I0BCAAAB
|
Haemaccel | Gelatin | Nutrition and Blood | No data available |
|
Isoplex 4% infusion 1litre bags
0902022I0BEAAAC
|
Isoplex | Gelatin | Nutrition and Blood | No data available |
|
Isoplex 4% infusion 500ml bags
0902022I0BEABAA
|
Isoplex | Gelatin | Nutrition and Blood | No data available |
|
Polygeline 17.5g/500ml solution for injection bottles
0902022I0AAABAB
|
Gelatin | Gelatin | Nutrition and Blood | No data available |
|
Volplex 4% infusion 1litre bags
0902022I0BDABAC
|
Volplex | Gelatin | Nutrition and Blood | No data available |
|
Volplex 4% infusion 500ml bags
0902022I0BDAAAA
|
Volplex | Gelatin | Nutrition and Blood | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.